Curaleaf Holdings Inc. faces a challenging day as it sees a notable drop in stock value.
Curaleaf Holdings Inc. is experiencing a decline in stock price today, down 1.44% to CA$14.41. This downturn comes amid broader market pressures affecting the cannabis sector and the S&P/TSX Composite Index.
Advertisement
Curaleaf Holdings Inc.
CURA.TO
CURA.TO
Curaleaf Holdings Inc.
WealthAwesomeMarket cap
$3.87B
52W high
$20.93
52W low
$7.77
1W change
-12.98%
Beta
1.64
Analyst Price Targets
Based on analyst covering CURA · as of Oct 1, 2026
Wall Street analysts forecast CURA stock price to rise 29.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.93
+29.5% Upside
Previously C$18.86 on Sep 30, 2026
Current Price
C$14.62
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CURA's historical volatility
30-Day Vol
56.7%
Annualized
90-Day Vol
61.2%
Annualized
Trend (90d)
+39.1%
Annualized drift
90d Mean
C$16.81
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$15.32 | C$12.60 – C$18.62 |
| 60 trading days | C$16.05 | C$12.17 – C$21.16 |
| 90 trading days | C$16.81 | C$11.98 – C$23.59 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be cautious as Curaleaf navigates significant headwinds, particularly related to regulatory uncertainties in the cannabis industry.
Curaleaf Holdings Inc. market cap: CA$3.87 billion
Despite its substantial market cap, Curaleaf's profit margin remains negative, indicating ongoing financial challenges.
Bull case
If the regulatory environment improves and cannabis is federally recognized for medical use, Curaleaf could see a strong rebound. This change could open up new opportunities and boost investor confidence.
Bear case
However, ongoing procedural delays and a sluggish market could continue to hold Curaleaf back, especially as the cannabis sector faces increased scrutiny. These challenges may keep the company from reaching its full potential in the near term.
Market Context
Advertisement
The cannabis sector is facing significant challenges as the S&P/TSX Composite Index falls to a two-month low. Curaleaf's decline reflects these broader market trends, particularly after the Drug Enforcement Administration's recent procedural delays that have left many cannabis stocks vulnerable.
Regulatory Pressures
The recent pause in the Drug Enforcement Administration's rescheduling proceedings for cannabis has created uncertainty in the market. This has negatively impacted investor sentiment, leading to declines in stocks like Curaleaf Holdings Inc. As regulatory clarity remains elusive, investors are left questioning the future growth potential of the cannabis sector.
Looking Ahead
As Curaleaf navigates these turbulent waters, investors should keep an eye on regulatory developments and market sentiment. The company's ability to adapt to changing conditions will be crucial in determining its future performance. For more insights on Curaleaf, visit our detailed analysis on Curaleaf Holdings Inc..
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
